Reactivation of SARS-CoV-2 after Rituximab in a Patient with Multiple Sclerosis
Gauruv Bose, Kristin Galetta
Topics & Concepts
MedicineRituximabMultiple sclerosisHypogammaglobulinemiaSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)CD20ImmunologyCoronavirus disease 2019 (COVID-19)Respiratory systemAntibodyInternal medicineDiseaseInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchPeripheral Neuropathies and DisordersMultiple Sclerosis Research Studies